These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 16675323

  • 21. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
    van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ.
    Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
    [Abstract] [Full Text] [Related]

  • 22. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML, Bussamra MH, Saraiva-Romanholo BM, Martins MA, Okay TS, Rodrigues JC.
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [Abstract] [Full Text] [Related]

  • 23. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma.
    Jatakanon A, Kharitonov S, Lim S, Barnes PJ.
    Thorax; 1999 Feb; 54(2):108-14. PubMed ID: 10325913
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.
    Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH.
    Am J Respir Crit Care Med; 1995 Jul; 152(1):45-52. PubMed ID: 7599861
    [Abstract] [Full Text] [Related]

  • 26. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids.
    Godon P, Boulet LP, Malo JL, Cartier A, Lemière C.
    Eur Respir J; 2002 Dec; 20(6):1364-9. PubMed ID: 12503690
    [Abstract] [Full Text] [Related]

  • 27. Observational study of the natural history of eosinophilic bronchitis.
    Berry MA, Hargadon B, McKenna S, Shaw D, Green RH, Brightling CE, Wardlaw AJ, Pavord ID.
    Clin Exp Allergy; 2005 May; 35(5):598-601. PubMed ID: 15898981
    [Abstract] [Full Text] [Related]

  • 28. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
    Jiang YW, Sun YC, Zhou QT, Gai XY, Cao WL, Yao WZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC, International Mepolizumab Study Group.
    Am J Respir Crit Care Med; 2007 Dec 01; 176(11):1062-71. PubMed ID: 17872493
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma.
    Gibson PG, Saltos N, Borgas T.
    J Allergy Clin Immunol; 2000 Apr 01; 105(4):752-9. PubMed ID: 10756226
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).
    Ställberg B, Pilman E, Skoogh BE, Hermansson BA.
    Respir Med; 2007 Mar 01; 101(3):610-5. PubMed ID: 16889952
    [Abstract] [Full Text] [Related]

  • 37. Combined mediator blockade or topical steroid for treating the unified allergic airway.
    Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ.
    Allergy; 2007 Jan 01; 62(1):73-80. PubMed ID: 17156345
    [Abstract] [Full Text] [Related]

  • 38. Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma?
    Lex C, Jenkins G, Wilson NM, Zacharasiewicz A, Erin E, Hansel TT, Bush A, Payne DN.
    Pediatr Pulmonol; 2007 Mar 01; 42(3):298-303. PubMed ID: 17262857
    [Abstract] [Full Text] [Related]

  • 39. Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial.
    Neighbour H, Boulet LP, Lemiere C, Sehmi R, Leigh R, Sousa AR, Martin J, Dallow N, Gilbert J, Allen A, Hall D, Nair P.
    Clin Exp Allergy; 2014 Apr 01; 44(4):508-16. PubMed ID: 24286456
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.